| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |